Out at Nature Methods just now! nature.com/articles/s4159… We present #SN2N, a flagship level unsupervised denoising solution. It’s fully competitive with supervised learning without needing large training-set and clean ground-truth, using 1 noisy frame for training. (1/n)

Rockstars from the lab presenting our latest work at #PNI2024

Huge congratulations on this milestone review.

Huge congratulations to the team on such an amazing piece of work.

At npj Imaging we are very excited about radiotheranostics.

In npj Journals Imaging. we treated some lucky mice to low, normal, and high-zinc chow—and turns out, their prostates have a lot to say on MRI. Great collaboration effort with @VeronicaClavij8 A. Dean Sherry UT Southwestern Medical Center Uniklinikum Tübingen DKFZ MGH Martinos Center nature.com/articles/s4430…

Coming back here just to report that I still hate editorial manager

Come follow me elsewhere!

Scientists have used a chemical compound to light up treatment-resistant cancers on imaging scans. The breakthrough could help medical professionals better target and treat cancer. King's Faculty of Life Sciences & Medicine kcl.ac.uk/news/scientist…

Great to see this collaborative paper out Nature Communications. Tim Witney's team developed a PET radiotracer that distinguishes high/low NRF2 antioxidant pathway activation, including in our CRUK Lung Centre PDX models. Congrats Hannah Greenwood and team! 👏 nature.com/articles/s4146…

Anyone working on NRF2 activation in cancer? If so, this might be of interest to you. nature.com/articles/s4146…

I wish you all a Merry X-Mas. If you have the time, I invite you to listen to the latest ESMI podcast - Dive into Imaging Science, in which I talk about an exciting paper on how to make tissue transparent in vivo: e-smi.eu/podcast/

Research led by Tim Witney from 🇬🇧 King's Faculty of Life Sciences & Medicine shows that a new #radiotracer – an injected compound used in #PET scans – could help inform doctors that a patients aggressive #cancer will not respond to #chemotherapy before treatment is given. dlvr.it/TH94TP

Dear wonderful imaging community, I'm running for (vice)president of European Society for Molecular Imaging - ESMI . A society I care deeply about. The election opens on 18th February for all members of the society. I would be very grateful for your vote. 🙏 Tim

Seeing the unseen! FAP-PET unlocks TME visualization, allowing the imaging of cancer-associated fibroblasts (CAFs), notably in tumors with low metabolic activity. aacrjournals.org/cancerdiscover…

With the appointment of the new chief executive of UK Research and Innovation “imminent”, Miles Padgett and I explore the key issues s/he will face. “Eight critical questions for the new chief executive of UKRI” wonkhe.com/blogs/eight-cr… via @wonkhe

Voting is now open for (vice)president of the European Society for Molecular Imaging - ESMI and closes on 27th February. It's an honour to stand for election. Thank you to all those who chose to vote for me. 🙏

In the Spotlight: Hidden in Plain Sight: Clinical Imaging of the Tumor Microenvironment with PET aacrjournals.org/cancerdiscover… By Timothy Witney Tim Witney King's College London

Submission alert: we have opened a new collection on 'Super-resolution Imaging' at #npjImaging npj Journals!